MX2012005264A - Portador de suministro. - Google Patents

Portador de suministro.

Info

Publication number
MX2012005264A
MX2012005264A MX2012005264A MX2012005264A MX2012005264A MX 2012005264 A MX2012005264 A MX 2012005264A MX 2012005264 A MX2012005264 A MX 2012005264A MX 2012005264 A MX2012005264 A MX 2012005264A MX 2012005264 A MX2012005264 A MX 2012005264A
Authority
MX
Mexico
Prior art keywords
carrier
delivery carrier
hard gelatin
loaded
capsule shells
Prior art date
Application number
MX2012005264A
Other languages
English (en)
Inventor
David Delmarre
Marie-Sophie Lina Martina
Vertommen Jan Emiel Godelieve
Original Assignee
Capsugel Belgium Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsugel Belgium Nv filed Critical Capsugel Belgium Nv
Publication of MX2012005264A publication Critical patent/MX2012005264A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención presente se relaciona a un portador de suministro líquido novedoso que comprende un grado específico de caprilato de glicerilo y PEG-40 aceite de ricino hidrogenado en cantidades particulares; este portador puede ser cargado sustancias ligera o deficientemente solubles en agua y rellenado en envolturas duras de cápsula de gelatina para la administración final a un sujeto; también se describen composiciones de relleno que comprenden tal portador de suministro y cápsulas duras de gelatina rellenas del portador y la composición de la invención; el portador de suministro de la invención demostró ser compatible con ambas de las envolturas duras de cápsula de gelatina y las sustancias cargadas en ellas.
MX2012005264A 2009-11-09 2010-10-26 Portador de suministro. MX2012005264A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25935509P 2009-11-09 2009-11-09
US37752810P 2010-08-27 2010-08-27
PCT/IB2010/054844 WO2011055269A1 (en) 2009-11-09 2010-10-26 Delivery carrier

Publications (1)

Publication Number Publication Date
MX2012005264A true MX2012005264A (es) 2012-07-03

Family

ID=43416906

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012005264A MX2012005264A (es) 2009-11-09 2010-10-26 Portador de suministro.

Country Status (12)

Country Link
US (1) US9333177B2 (es)
EP (1) EP2498760B1 (es)
JP (1) JP2013510135A (es)
KR (1) KR20120105465A (es)
CN (1) CN102711741A (es)
AU (1) AU2010316741A1 (es)
BR (1) BR112012010895A2 (es)
CA (1) CA2779005A1 (es)
EA (1) EA201290315A1 (es)
MX (1) MX2012005264A (es)
TW (1) TW201119690A (es)
WO (1) WO2011055269A1 (es)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8178516B2 (en) * 1992-06-30 2012-05-15 Sylvan Labs, LLC Compositions and method for treatment of chronic inflammatory diseases
GB9525194D0 (en) * 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
WO1998040051A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
US20030104048A1 (en) 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
JP4994039B2 (ja) * 2003-11-26 2012-08-08 スパーナス ファーマシューティカルズ インコーポレイテッド 脂溶性または疎水性化合物の送達に有用なミセル系
PE20050596A1 (es) * 2003-12-19 2005-10-18 Novartis Ag Microemulsion que comprende un inhibidor renina
MX2007007038A (es) * 2004-12-09 2008-03-07 Insys Therapeutics Inc Formulacion de dronabinol en temperatura ambiente.
DK2985026T3 (da) * 2005-04-15 2022-10-31 Clarus Therapeutics Inc Farmaceutiske leveringssystemer til hydrofobe lægemidler og sammensætninger dermed
US8252326B2 (en) * 2005-06-01 2012-08-28 Catalent Australia Pty Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10

Also Published As

Publication number Publication date
TW201119690A (en) 2011-06-16
AU2010316741A1 (en) 2012-05-24
EP2498760B1 (en) 2015-07-01
EA201290315A1 (ru) 2012-10-30
US9333177B2 (en) 2016-05-10
US20120308655A1 (en) 2012-12-06
BR112012010895A2 (pt) 2019-09-24
CA2779005A1 (en) 2011-05-12
WO2011055269A1 (en) 2011-05-12
EP2498760A1 (en) 2012-09-19
CN102711741A (zh) 2012-10-03
JP2013510135A (ja) 2013-03-21
KR20120105465A (ko) 2012-09-25

Similar Documents

Publication Publication Date Title
HK1182010A1 (en) Liquid pharmaceutical composition for the delivery of active ingredients
CO6290641A2 (es) Preparacion de capsula que contiene los ingredientes farmaceuticamente activos liquidos y solidos, la cual presenta exelentes propiedades de los ingredientes farmaceuticamente activos
MX2014015899A (es) Capsula de estradiol soluble para insercion por via vaginal.
TN2010000152A1 (en) Pharmaceutical compositions
PL2244593T3 (pl) Kapsułka zawierająca składniki odżywcze i sposób dostarczania cieczy odżywczej z kapsułki
CL2011002432A1 (es) Composicion que comprende al menos una enzima digestiva y al menos un portador, en donde el portador comprende celulosa microcristalina que tiene un tamaño de particulas mayor que 100 um; una forma de dosificacion; el envase que la contiene; un proceso para preparar la composicion; y sus usos.
EP2400851A4 (en) COMPOSITION AND ACTIVE COMPOSITION OF BISPHOSPHONATES
IL220465A0 (en) Methods and compositions for stable liquid drug formulations
IL218071A0 (en) Novel pharmaceutical formulations to prevent the misuse of medicinal drugs
EP2281576A4 (en) POLYMERS MICRES WITH ACTIVE TARGETING AND A CAPACITATED ACTIVE SUBSTANCE AND A CAPACITATED MEDICAL COMPOSITION
MY162175A (en) Aqueous drug delivery system
WO2011067667A3 (en) Fexofenadine microcapsules and compositions containing them
EP2488210A4 (en) METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING IN VITO OR IN VITRO-ADMINISTERED OLIGONUCLEOTIDE MEDICAMENTS
MX344163B (es) Formulaciones farmacéuticas de loratadina para encapsulación y combinaciones de las mismas.
AR092840A1 (es) Elaboracion de degarelix
EP2150235A4 (en) Capsule formulation coated with nanoparticles for the purpose of dermal drug administration
MX2012005264A (es) Portador de suministro.
WO2015024577A3 (fr) Composition a base de safranal
MX2013008635A (es) Mejoras de y relacionadas con composiciones.
WO2011079317A3 (en) Ultrasound-activated nanoparticles as imaging agents and drug delivery vehicles
IN2014DN09091A (es)
JP2013510135A5 (es)
PH12014502170A1 (en) Drug composition and soft capsule drug sealing the drug composition
GB201008049D0 (en) Composition
WO2012178184A3 (en) Removable protective shell for imaging agents and bioactive substances

Legal Events

Date Code Title Description
FA Abandonment or withdrawal